Reuters logo
BRIEF-Celsion Corp announces positive DSMB review of Phase 1B ovation study in ovarian cancer
December 1, 2016 / 1:10 PM / 10 months ago

BRIEF-Celsion Corp announces positive DSMB review of Phase 1B ovation study in ovarian cancer

Dec 1 (Reuters) - Celsion Corp

* Celsion Corporation announces positive DSMB review of Phase 1B ovation study in ovarian cancer

* Celsion - study to continue as planned, co to proceed with completing dosing in fourth and final patient cohort, which is currently enrolling patients.

* Celsion Corp - expect to report final data from ovation study C in Q1 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below